J&J Proposes $5.5 Billion Deal to Settle 76,000 Ovarian Cancer Talc Claims

似たピン

• 司法2026/09/23@LawDesk

  Baltimore Jury Orders J&J to Pay $1.56 Billion Over Baby Powder Cancer

  Clarence M. Mitchell Jr. Courthouse, 100 North Calvert Street, Baltimore, Maryland 21202, United States

  開始 2025/12/22確定確度 81%275 日前The Baltimore Banner's report of Tuesday 23 December 2025 says "The jury returned the verdict in favor of Cherie Craft ... on Monday in Baltimore Circuit Court", i.e. Monday 22 December 2025 (Bloomberg: "Jurors in state court in Baltimore late Monday"); no time of day is reported, so the pin is all day.^[1]

  A Baltimore City jury awarded Cherie Craft $59.84 million in compensatory and $1.5 billion in punitive damages, finding J&J's talc baby powder exposed her to the asbestos behind her peritoneal mesothelioma - the largest talc verdict for a single plaintiff. J&J said it would appeal.

  $1.6B

  0.69

  00
• 企業2026/09/23@HealthDesk

  J&J Completes Its $1 Billion Acquisition of Firefly Bio

  South San Francisco, San Mateo County, California, United StatesJohnson & Johnson·…

  

  開始 2026/07/29確定確度 87%56 日前"NEW BRUNSWICK, NJ (July 29, 2026) - Johnson & Johnson (NYSE: JNJ^[1][3]) today announced the successful completion of its acquisition of Firefly Bio, Inc. ... for $1 billion in cash"; the 8-K furnishing it gives "Date of report (Date of earliest event reported): July 29, 2026".

  Johnson & Johnson closed its $1 billion cash purchase of Firefly Bio, the South San Francisco biotech behind the Firelink degrader antibody conjugate platform for KRAS-driven and other hard-to-treat solid tumours.

  $1B

  0.65

  00
• 健康2026/09/23@HealthDesk

  J&J Signs a Drug-Pricing Deal With Trump and Joins TrumpRx

  Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson·…

  

  開始 2026/01/08確定確度 86%258 日前J&J's release is datelined "New Brunswick, N.J. – JANUARY 8, 2026" and says the company "today announced a voluntary agreement with the Trump Administration"; coverage followed on 9 January.^[1]

  Johnson & Johnson signed a voluntary most-favored-nation drug-pricing agreement with the Trump administration, selling medicines through TrumpRx.gov and to Medicaid at prices comparable to other developed countries in exchange for an exemption from pharmaceutical tariffs, and announced two new US plants in Pennsylvania and North Carolina.

  0.64

  00
• 企業2026/09/23@HealthDesk

  Apollo in Talks to Buy J&J's DePuy Synthes for About $20 Billion

  Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson·…

  

  開始 2026/09/11確定確度 82%12 日前The disclosure is Bloomberg's report, dated "September 11, 2026" (Yahoo's^[1][2][5] syndicated copy went up at 22:26 UTC and quotes Friday's closing share prices); Reuters' write-up the same evening says "Bloomberg News reported on Friday", and Quartz's 14 September story is a follow-up, so the pin is the all-day 11 September.

  Bloomberg reported that Apollo Global Management is in talks to buy DePuy Synthes, J&J's $9.3 billion-a-year orthopaedics unit, at a value close to $20 billion, with a deal possible within weeks though J&J could still spin the unit off instead.

  $20B

  0.64

  00
• 健康2026/09/23@HealthDesk

  J&J Announces Plan to Spin Off DePuy Synthes

  Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson·…

  

  開始 2025/10/14確定確度 90%344 日前The release is datelined "NEW BRUNSWICK, NJ, October 14, 2025 - Johnson & Johnson ... today announced the Company's intent to separate its Orthopaedics business"; it states no time of day (CNBC's^[3] report was up at 6:29 a.m. EDT and J&J's X post at 6:40 a.m. EDT), so the pin is the all-day 14 October.

  Johnson & Johnson said it would separate its roughly $9.2 billion-a-year orthopaedics business into a standalone company called DePuy Synthes within 18 to 24 months, and named former Smith & Nephew chief Namal Nawana to run it.

  0.63

  00
• 健康2026/09/23@HealthDesk

  DePuy Synthes、Johnson & Johnsonから分離

  325 Paramount Drive, Raynham, Massachusetts 02767, United StatesJohnson & Johnson·…

  

  開始 2027/07/01推定確度 71%281 日後2026年6月28日締め四半期のJ&Jの10-Qは、2025年10月14日の「当初発表から18〜24か月以内の完了」(2027年4月半ば〜10月半ば)を目標としており、Joseph Wolk CFOは7月に、J&Jは「2027年半ばの分離に向け順調だ」と述べた(Bloomberg)。「2027年半ば」は年央、すなわち2027年7月1日と解釈され、この期間内に収まる。^[1]

  Johnson & Johnsonの整形外科事業は、DePuy Synthesとしてグループから分離される見通し。非課税スピンオフか売却かの選択肢があり、Apolloが約200億ドルで交渉中。J&Jは2027年半ばの分離に向け順調だとしている。

  0.62

  00
• 健康2026/09/23@HealthDesk

  J&J Picks Wilson, North Carolina for a Second 500-Job Drug Plant

  Wilson, Wilson County, North Carolina, United StatesJohnson & Johnson·…

  

  開始 2026/01/09確定確度 87%257 日前The governor's release is dated "Friday, January 9, 2026" and begins "Today Governor Josh Stein announced Johnson & Johnson ... will expand its presence in North Carolina"; the Wilson Times^[3] says Stein "made the announcement Friday afternoon".

  North Carolina Governor Josh Stein announced that Johnson & Johnson will build a second multibillion-dollar plant in Wilson, a drug product manufacturing facility for cancer and neurology medicines expected to create up to 500 jobs, beside the $2 billion biologics campus it is already building there.

  0.61

  00
• 法律2026/09/23@LawDesk

  Google and DOJ Due to File a Joint Proposed Final Judgment in Ad Tech Case

  Albert V. Bryan United States Courthouse, 401 Courthouse Square, Alexandria, VA 22314, United StatesGoogle·…

  

  開始 2026/10/02予定確度 86%9 日後The court's 2 September 2026 order (ECF 1857) directs the parties to "file one jointly proposed Final Judgment" "within 30 days of the date of this Order", which falls on 2 October 2026, and AdExchanger^[1] reports "Both parties have until October 2 to submit their proposed final judgments".

  Google and the Justice Department must file one jointly proposed Final Judgment in the ad tech antitrust case by 2 October 2026, writing Judge Brinkema's behavioral remedies into an order that takes effect 60 days after she enters it.

  0.61

  00
• 健康2026/09/23@HealthDesk

  Abbott Settles DOJ Infant Formula Claims for $385 Million

  Abbott Laboratories·…Sturgis, Saint Joseph County, Michigan, 49091, United States

  開始 2026/09/14確定確度 88%9 日前The release is datelined "ABBOTT PARK, Ill., Sept. 14, 2026" and says Abbott "has reached an agreement"; the DOJ release is dated Monday, September 14, 2026.^[1]

  Abbott will pay about $385 million ($384,999,040) to resolve Justice Department, state and whistleblower claims over powdered infant formula made at its Sturgis, Michigan, plant, the site of the 2022 recall. Abbott admits no liability, and the government has closed its criminal investigation.

  $385M

  0.60

  00
• 金融2026/09/23@HealthDesk

  J&J Q2 2026 Results: $25.3B Sales, 2026 Outlook Raised

  Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson·…

  

  開始 2026/07/15 12:30確定確度 83%70 日前Confirmed by J&J's release dated "New Brunswick, N.J. (July 15, 2026)", which says it "will conduct a conference call with investors to discuss this earnings release today at 8:30 a.m., Eastern Time" (12:30 UTC; the edited transcript is stamped "JULY 15, 2026 / 12:30PM GMT").^[1]

  Johnson & Johnson reported second-quarter sales of $25.3 billion, up 6.6%, and adjusted EPS of $2.90, and raised its 2026 outlook to about $101.1 billion in sales and $11.68 adjusted EPS at the midpoint.

  0.60

  00
• 健康2026/09/23@HealthDesk

  Lilly Agrees to Acquire Centessa for Up to $7.8 Billion

  Eli Lilly·…Eli Lilly and Company Corporate Center, East McCarty Street, Indianapolis, Indiana 46206, United States

  開始 2026/03/31確定確度 87%176 日前The joint release is datelined "INDIANAPOLIS and BOSTON and LONDON, March 31, 2026" and says the companies "today announced a definitive agreement for Lilly to acquire Centessa".^[1]

  Lilly agrees to buy Centessa Pharmaceuticals, maker of the orexin agonist cleminorexton for narcolepsy, for $38 a share in cash (about $6.3 billion) plus a CVR worth up to $1.5 billion more; the deal closed on 24 June 2026.

  $7.8B

  0.59

  00
• 司法2026/09/23@LawDesk

  Judge Approves the DOJ's HPE-Juniper Settlement Over States' Objections

  Robert F. Peckham United States Courthouse and Federal Building, 280 South 1st Street, San Jose, California 95113, United States

  

  開始 2026/08/12確定確度 85%42 日前The order granting the motion for entry of final judgment (Case 5:25-cv-00951-PCP, Document 482) is 'Filed 08/12/26' and signed 'Dated: August 12, 2026' by P. Casey Pitts; no time is given, so it is an all-day date.^[1]

  Judge P. Casey Pitts entered the consent decree clearing HPE's Juniper Networks deal in a 41-page order that found DOJ leadership overrode its own antitrust staff, but held that 12 states and DC had not shown the Instant On sale and Mist source-code licence were against the public interest.

  0.59

  00